The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance

  • A.P. Toner
  • , F. McLaughlin
  • , F.J. Giles
  • , F.J. Sullivan
  • , E. O'Connell
  • , L.A. Carleton
  • , L. Breen
  • , G. Dunne
  • , A.M. Gorman
  • , J.D. Lewis
  • , S.A. Glynn

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

12 Citations (Scopus)
Original languageUndefined/Unknown
JournalBritish Journal Of Cancer
DOIs
Publication statusPublished - 2013

Cite this